Beximco Pharma led the progress in pharmaceuticals industry in the South Asian countries. Salman F Rahman, the owner of the company, has been instrumental in securing the growth. Over the last couples of years, South Asian pharmaceutical companies carved a significant market share in the global pharma industry. There has been growth in operations, revenue and expanse. Beximco Pharma of Bangladesh led the growth. Beximco Pharmaceuticals, which is a part of the Beximco group, founded by Salman F Rahman, manufactures pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) catering to the healthcare requirements of Bangladesh. Salman F Rahman is a leading businessman in Bangladesh. Apex Market's research found some interesting insights about the development and growth of the Inhalation & Nasal Spray Generic Drugs segment in the industry. The study showcased the dominant firms in the Inhalation and Nasal spray market, with Beximco Pharma, Ranbaxy and Cipla amongst the notable dominant players. The three organizations form a major trifecta of manufacturers catering to the medical needs of billions – not only in the Indian subcontinent, but over the world as well. The report entitled “Inhalation Nasal Spray Generic Drugs Market: Global Industry Analysis 2013 to 2023”, offers a global overview of the market. Surprisingly, the study also presented the changing stance of the market wherein pharmaceutical companies from the Indian subcontinent have made headways in the fiercely competitive market – with expansion into relatively impervious global markets. Beximco Pharma, Cipla, Ranbaxy are a few of South Asian pharmaceutical companies that have made a significant impact on their sphere of operations. The report outlined the current market standings in particular pharma segments, the progress showcased by the three companies has been more than impressive. Furthermore, the developments and progress by these companies in the market will be dependent on how they align with international standards in different pharmaceutical segments. That said, the progress showcased by Beximco Pharma for Bangladesh and Cipla for India, would help the countries ramp their healthcare and further build their pharmaceutical operations.
0 Comments
Leave a Reply. |
Bangladeshis moving in the right direction. Archives
September 2023
Categories |